{"id":833197,"date":"2025-04-02T16:16:33","date_gmt":"2025-04-02T20:16:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/"},"modified":"2025-04-02T16:16:33","modified_gmt":"2025-04-02T20:16:33","slug":"elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/","title":{"rendered":"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Introduction of EluPro at<\/em><br \/>\n        <em>Heart\u00a0Rhythm\u00a02025 in San Diego, April 25-27,\u00a02025<\/em>\n      <\/p>\n<p align=\"justify\">SILVER SPRING, Md., April  02, 2025  (GLOBE NEWSWIRE) &#8212; Elutia Inc. (Nasdaq: ELUT) (\u201cElutia\u201d or the \u201cCompany\u201d), a pioneer in drug-eluting biomatrix products, is proud to announce the debut of its EluPro\u2122 Antibiotic-Eluting BioEnvelope designed for cardiac implantable electronic devices (CIEDs) and neurostimulators at the Heart Rhythm Society\u2019s annual meeting (HRS 2025). Attendees will have the opportunity to experience firsthand the soft, conforming feel of EluPro and discover how its natural biomatrix supports healing while delivering trusted antibiotics to reduce bacterial colonization.<\/p>\n<p align=\"justify\">Engineered for both performance and handling, EluPro features a proprietary biomatrix that drapes naturally around CIEDs, avoiding the rough, stiff feel often associated with synthetic alternatives. Combined with a trusted dual-antibiotic combination, EluPro offers physicians a solution designed for both efficacy and ease of use without compromise.<\/p>\n<p align=\"justify\">\u201cWe are thrilled to introduce EluPro at HRS 2025 and give clinicians the opportunity to feel the difference biology makes,\u201d said Dr. Kimberly Mulligan, GM and VP of Elutia\u2019s Cardiovascular Division. \u201cWith its soft, conforming biomatrix and proven antibiotics, EluPro represents a meaningful step forward in CIED antibiotic envelope technology.\u201d<\/p>\n<p align=\"justify\">Elutia invites physicians and medical professionals to experience EluPro firsthand at booth #2418 at the San Diego Convention Center from April 25-27, 2025. Attendees interested in scheduling a meeting with Elutia during the conference may register through the HRS 2025 meeting portal <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cj24Dso4TM1XDWJQGEP7hTa97gjv1fmfoHGMZ_4ZVAeVs45aa91qbIok3JPmabnSEEm_L5MDlhwHJRUBXyGl-0y1RqmeGoamRbcbWzdCIIS4_uFbOEL3fOQtXqjVAZru41tOlsXm2SUwpNJlpUXaJw==\" rel=\"nofollow\" target=\"_blank\">here<\/a> or contact ir@elutia.com.<\/p>\n<p align=\"justify\">Those unable to attend can contact Elutia to speak with a representative and learn more about how EluPro is redefining CIED protection.<\/p>\n<p align=\"justify\">\n        <strong>About Elutia<\/strong>\n      <\/p>\n<p align=\"justify\">Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia\u2019s mission is humanizing medicine so patients can thrive without compromise. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ikhYvZ2w2a0KVzU0sf00u94xqo2Y_AO01J9WXX6Ap6neLYZhnnkUbl-Ltd2JnpH0LzHSbTgbHH7fRsyxO57WkQ==\" rel=\"nofollow\" target=\"_blank\"><u>www.Elutia.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by words such as \u201cprojects,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201cbelieves,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cestimates,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cpotential,\u201d \u201cpromise\u201d or similar references to future periods. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. Forward-looking statements contained in this press release include, without limitation, any statements we make regarding the potential for EluPro to represent a meaningful step forward in CIED antibiotic envelope technology. These forward-looking statements are based on our management\u2019s beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied in the forward-looking statements, including, but not limited to the following: the risk that clinical research data may not match preclinical study data; our ability to successfully commercialize, market and sell our EluPro product; our ability to continue as a going concern; our ability to achieve or sustain profitability; the risk of product liability claims and our ability to obtain or maintain adequate product liability insurance; our ability to defend against the various lawsuits and claims related to our recalled FiberCel and other viable bone matrix products and avoid a material adverse financial consequence from those lawsuits and claims; our ability to prevail in lawsuits and claims seeking indemnity, contribution and insurance coverage for FiberCel and other viable bone matrix product liabilities; the continued and future acceptance of our products by the medical community; our ability to enhance our products, expand our product indications and develop, acquire and commercialize additional product offerings; our dependence on our commercial partners and independent sales agents to generate a substantial portion of our net sales; our dependence on a limited number of third-party suppliers and manufacturers, which, in certain cases are exclusive suppliers for products essential to our business; our ability to successfully realize the anticipated benefits of the sale of our Orthobiologics business; physician awareness of the distinctive characteristics, benefits, safety, clinical efficacy and cost-effectiveness of our products; our ability to compete against other companies, most of which have longer operating histories, more established products and\/or greater resources than we do; pricing pressure as a result of cost-containment efforts of our customers, purchasing groups, third-party payors and governmental organizations could adversely affect our sales and profitability; our ability to obtain regulatory approval or other marketing authorizations by the FDA and comparable foreign authorities for our products and product candidates; our ability to obtain, maintain and adequately protect our intellectual property rights; and other important factors which can be found in the \u201cRisk Factors\u201d section of Elutia\u2019s public filings with the Securities and Exchange Commission (\u201cSEC\u201d), including Elutia\u2019s Annual Report on Form 10-K for the year ended December 31, 2024, as such factors may be updated from time to time in Elutia\u2019s other filings with the SEC, accessible on the SEC\u2019s website at www.sec.gov and the Investor Relations page of Elutia\u2019s website at https:\/\/investors.elutia.com. Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. Any forward-looking statement made by Elutia in this press release is based only on information currently available and speaks only as of the date on which it is made. Except as required by applicable law, Elutia expressly disclaims any obligations to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.<\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Matt Steinberg<br \/>FINN Partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=buR3ttckULvJKKMor9gwt7QW4wjKB42mDHlVBYefD84BqVYMonq88JyIZlBI02WEY6SnPbOLjQG006EMFnvGbbo3pYTKJpR4TGi6ewGs1IoWWFsxhYvy9uAQmWi_FScIZBR76bf224BCYcNNWIDDmCHbFo9r-abp3j_bcn6yq7tBrl0wKzdUSmUnGU74r5aBUoLyNozzprEYC9BdyACYZHOLBblsLckDX5lw8dIeCpxzQDOOmnt4VttYQUwRaLVl1ZMQj6yT6xYwzatDqjhBzAuhjeoOCdGia6kZ2ZrwfdRFFApgeT73cLnHxXQuiSJa\" rel=\"nofollow\" target=\"_blank\"><u>matt.steinberg@finnpartners.com<\/u><\/a><\/p>\n<p>This press release was published by a CLEAR\u00ae Verified individual.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OGRiMWQyODEtZTZmMC00ZDBiLWJkZmEtMjIyZTdhYmM0YWJlLTExOTEyNzYtMjAyNS0wNC0wMi1lbg==\/tiny\/Elutia-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Introduction of EluPro at Heart\u00a0Rhythm\u00a02025 in San Diego, April 25-27,\u00a02025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) &#8212; Elutia Inc. (Nasdaq: ELUT) (\u201cElutia\u201d or the \u201cCompany\u201d), a pioneer in drug-eluting biomatrix products, is proud to announce the debut of its EluPro\u2122 Antibiotic-Eluting BioEnvelope designed for cardiac implantable electronic devices (CIEDs) and neurostimulators at the Heart Rhythm Society\u2019s annual meeting (HRS 2025). Attendees will have the opportunity to experience firsthand the soft, conforming feel of EluPro and discover how its natural biomatrix supports healing while delivering trusted antibiotics to reduce bacterial colonization. Engineered for both performance and handling, EluPro features a proprietary biomatrix that drapes naturally around CIEDs, avoiding the rough, stiff feel often associated with synthetic alternatives. Combined with &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-833197","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Introduction of EluPro at Heart\u00a0Rhythm\u00a02025 in San Diego, April 25-27,\u00a02025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) &#8212; Elutia Inc. (Nasdaq: ELUT) (\u201cElutia\u201d or the \u201cCompany\u201d), a pioneer in drug-eluting biomatrix products, is proud to announce the debut of its EluPro\u2122 Antibiotic-Eluting BioEnvelope designed for cardiac implantable electronic devices (CIEDs) and neurostimulators at the Heart Rhythm Society\u2019s annual meeting (HRS 2025). Attendees will have the opportunity to experience firsthand the soft, conforming feel of EluPro and discover how its natural biomatrix supports healing while delivering trusted antibiotics to reduce bacterial colonization. Engineered for both performance and handling, EluPro features a proprietary biomatrix that drapes naturally around CIEDs, avoiding the rough, stiff feel often associated with synthetic alternatives. Combined with &hellip; Continue reading &quot;Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-02T20:16:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes\",\"datePublished\":\"2025-04-02T20:16:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/\"},\"wordCount\":1000,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/\",\"name\":\"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=\",\"datePublished\":\"2025-04-02T20:16:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/","og_locale":"en_US","og_type":"article","og_title":"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes - Market Newsdesk","og_description":"Introduction of EluPro at Heart\u00a0Rhythm\u00a02025 in San Diego, April 25-27,\u00a02025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) &#8212; Elutia Inc. (Nasdaq: ELUT) (\u201cElutia\u201d or the \u201cCompany\u201d), a pioneer in drug-eluting biomatrix products, is proud to announce the debut of its EluPro\u2122 Antibiotic-Eluting BioEnvelope designed for cardiac implantable electronic devices (CIEDs) and neurostimulators at the Heart Rhythm Society\u2019s annual meeting (HRS 2025). Attendees will have the opportunity to experience firsthand the soft, conforming feel of EluPro and discover how its natural biomatrix supports healing while delivering trusted antibiotics to reduce bacterial colonization. Engineered for both performance and handling, EluPro features a proprietary biomatrix that drapes naturally around CIEDs, avoiding the rough, stiff feel often associated with synthetic alternatives. Combined with &hellip; Continue reading \"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-02T20:16:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes","datePublished":"2025-04-02T20:16:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/"},"wordCount":1000,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/","name":"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=","datePublished":"2025-04-02T20:16:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNTk4OSM2ODQ4NTMxIzIxNzk3MDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-debut-elupro-at-hrs-2025-experience-the-difference-biology-makes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Elutia to Debut EluPro\u2122 at HRS 2025 \u2014 Experience the Difference Biology Makes"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=833197"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833197\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=833197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=833197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=833197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}